Jab1/COPS5 as a Novel Biomarker for Diagnosis, Prognosis, Therapy Prediction and Therapeutic Tools for Human Cancer
C-Jun activation domain-binding protein-1 (Jab1) involves in controlling cellular proliferation, cell cycle, apoptosis, affecting a series of pathways, as well as regulating genomic instability and DNA damage response (DDR). Jab1/COPS5 dysregulation contributes to oncogenesis by deactivating several...
Saved in:
Main Authors: | Guohong Liu (Author), Francois X. Claret (Author), Fuling Zhou (Author), Yunbao Pan (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2018-02-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Identification of lncRNA Signature of Tumor-Infiltrating T Lymphocytes With Potential Implications for Prognosis and Chemotherapy of Head and Neck Squamous Cell Carcinoma
by: Liping Wang, et al.
Published: (2022) -
Analysis of lncRNA-Mediated ceRNA Crosstalk and Identification of Prognostic Signature in Head and Neck Squamous Cell Carcinoma
by: Yunbao Pan, et al.
Published: (2019) -
Potential of Immune-Related Therapy in COVID-19
by: Chunjue Yuan, et al.
Published: (2021) -
Azelaic Acid Exerts Antileukemic Activity in Acute Myeloid Leukemia
by: Yunbao Pan, et al.
Published: (2017) -
Regulatory mechanisms and therapeutic potential of JAB1 in neurological development and disorders
by: Yu Yang, et al.
Published: (2023)